30 Apr 2021 09:00
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.
THE FOLLOWING ANNOUNCEMENT IS BEING MADE PURSUANT TO THE REQUIREMENTS OF RULE 19.6(C) OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE"), WHICH, INTER ALIA, REQUIRES A PARTY TO AN OFFER TO MAKE AN ANNOUNCEMENT AT THE END OF A PERIOD OF 12 MONTHS FROM THE DATE ON WHICH THE OFFER PERIOD ENDED CONFIRMING WHETHER IT HAS TAKEN, OR NOT TAKEN, THE COURSE OF ACTION SET OUT IN ITS STATED INTENTIONS.
30 April 2021
RM Special Holdings 3, LLC,a special purpose vehicle wholly-ownedby funds managed or advised by Redmile Group, LLC
Rule 19.6(c) confirmation of post-offer intention statementswith regard to Redx Pharma plc
RM Special Holdings 3 LLC ("Redmile" or the "Company") announces that, further to the completion of its recommended mandatory cash offer to acquire the entire issued and to be issued ordinary share capital of Redx Pharma Plc ("Redx"), other than the shares already held by Redmile, which was declared unconditional on 9 April 2020, the Company has duly confirmed in writing to The Panel on Takeovers and Mergers in accordance with the requirements of Rule 19.6(c) of the Code that the Company has complied with its post-offer statements of intent made pursuant to Rules 2.7(c)(iv) and 24.2 of the Code, as originally detailed in its announcement of 13 March 2020 and the Offer Document published on 9 April 2020.
Enquiries:
SPARK Advisory Partners Limited
(Financial Adviser to Redmile) Telephone: 020 3368 3550
Matt Davis
Redmile: Telephone: +1 415 489 9980